Centocor wins FDA approval for once-monthly arthritis therapy
Centocor Ortho Biotech, a wholly-owned subsidiary of Johnson & Johnson, has received the FDA approval for its Simponi for the treatment of moderately to severely active rheumatoid arthritis,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.